Search details
1.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Lancet Oncol
; 24(10): 1134-1146, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37797632
2.
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
BMC Cancer
; 23(1): 121, 2023 Feb 06.
Article
in English
| MEDLINE | ID: mdl-36747118
3.
Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma.
J Cell Mol Med
; 26(7): 1905-1917, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35315581
4.
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.
Br J Cancer
; 127(12): 2241-2248, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36261583
5.
Derivation and validation of a prediction model for patients with lung nodules malignancy regardless of mediastinal/hilar lymphadenopathy.
J Surg Oncol
; 126(8): 1551-1559, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35993806
6.
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE).
Oncologist
; 26(9): e1567-e1580, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34003545
7.
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study.
BMC Gastroenterol
; 21(1): 398, 2021 Oct 23.
Article
in English
| MEDLINE | ID: mdl-34688250
8.
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Gastric Cancer
; 24(4): 913-925, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33945049
9.
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
JAMA
; 326(10): 916-925, 2021 09 14.
Article
in English
| MEDLINE | ID: mdl-34519801
10.
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 21(6): 832-842, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32416073
11.
miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
J Cell Mol Med
; 23(9): 6295-6307, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31273950
12.
Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA.
Cancer Cell Int
; 19: 202, 2019.
Article
in English
| MEDLINE | ID: mdl-31384177
13.
MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2.
Cell Physiol Biochem
; 46(5): 2187-2196, 2018.
Article
in English
| MEDLINE | ID: mdl-29730656
14.
MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Cell Physiol Biochem
; 46(1): 93-106, 2018.
Article
in English
| MEDLINE | ID: mdl-29587281
15.
ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
Biochem Biophys Res Commun
; 503(4): 2583-2589, 2018 09 18.
Article
in English
| MEDLINE | ID: mdl-30049438
16.
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
Gastric Cancer
; 21(5): 782-791, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29488121
17.
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.
Br J Cancer
; 127(12): 2249, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36323881
18.
miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
Med Sci Monit
; 23: 1741-1750, 2017 Apr 10.
Article
in English
| MEDLINE | ID: mdl-28394882
19.
miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
Biochem Biophys Res Commun
; 470(1): 187-191, 2016 Jan 29.
Article
in English
| MEDLINE | ID: mdl-26772880
20.
MicroRNA-202 inhibits tumor progression by targeting LAMA1 in esophageal squamous cell carcinoma.
Biochem Biophys Res Commun
; 473(4): 821-827, 2016 05 13.
Article
in English
| MEDLINE | ID: mdl-27045085